Sotac Pharmaceuticals

Sotac Pharmaceuticals Deferred Tax Liabilities

Deferred Tax Liabilities of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 19, 2026.

Deferred Tax Liabilities

0.00INR

Last updated:

Deferred Tax Liabilities of Sotac Pharmaceuticals is 2022 0.00 INR. Deferred Tax Liabilities of Sotac Pharmaceuticals was 2021 491,000.00 INR. It decreases by % lower compared to the previous year.

The Sotac Pharmaceuticals Deferred Tax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Deferred Tax Liabilities
Date
Deferred Tax Liabilities
Jan 1, 2020
1.61 M INR
Jan 1, 2021
491,000.00 INR
Jan 1, 2022
0.00 INR
The Sotac Pharmaceuticals Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
0.00INR-100.00%
491,000.00INR-69.50%
1.61 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals Ltd., headquartered in Ahmedabad, Gujarat, operates in the Health Care sector, specializing in pharmaceutical manufacturing. The company develops and manufactures products such as Non Beta-Lactam tablets, capsules, syrups, and external preparations on a contract basis for various marketers. Its therapeutic portfolio covers Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Anti-Cold, Anti-Allergic, Derma Products, and a wide range of antibiotics including Non-IP-Lactams and Cephalosporin. Listed on 13 April 2023, Sotac employs 89 people and has subsidiaries including SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience. Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's Sotac Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Sotac Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Sotac Pharmaceuticals